Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Better Therapeutics Inc BTTX

Healthcare Biotechnology
Better Therapeutics, Inc. is a prescription digital therapeutics (PDT) company, which is engaged in developing a software-based novel form of cognitive behavioral therapy (CBT) to address the root causes of cardiometabolic diseases (CMDx). Its platform allows for the creation of multiple PDTs that are designed to treat patients with CBT, delivered digitally via an app, to address the underlying... see more

Recent & Breaking News (GREY:BTTX)

Better Therapeutics Completes Enrollment of Pivotal Trial for BT-001, a Prescription Digital Therapeutic for Type 2 Diabetes

Business Wire November 18, 2021

Better Therapeutics Appoints Major General Elder Granger, M.D., U.S. Army (retired) to its Board of Directors

Business Wire November 11, 2021

Better Therapeutics Appoints Thiago Licias de Oliveira as Its Chief People Officer

Business Wire November 4, 2021

Mass General Brigham Joins Better Therapeutics in Real World Evidence Study Collaboration

Business Wire November 2, 2021

Better Therapeutics Closes Business Combination and Debuts on Nasdaq

Business Wire October 29, 2021

Mountain Crest Acquisition Corp. II Stockholders Approve Business Combination with Better Therapeutics Inc.

GlobeNewswire October 27, 2021

Mountain Crest Acquisition Corp. II and Better Therapeutics, Inc. Announce Registration Statement Effectiveness and Scheduled Special Meeting to Approve Business Combination on October 27, 2021

GlobeNewswire October 12, 2021

Better Therapeutics to Participate in Lake Street's 5th Annual Best Ideas Growth (BIG5) Conference on September 14-15, 2021

Business Wire September 10, 2021

Better Therapeutics Highlights Recent Progress and Updates Outlook Through 2022

Business Wire September 9, 2021

Better Therapeutics Expands Real-World Evidence Study Initiative With Addition of Catalyst Health Network

Business Wire August 24, 2021

Lifshitz Law Firm, P.C. Announces Investigation of BMTC, WSFS, CAHC, CBAN, SCSG, INDB, EBSB, INSW, DSSI, MCAD, VER and O

PR Newswire May 3, 2021

INVESTIGATION ALERT: Halper Sadeh LLP Investigates MCAD, CAHC, ROT, MUDS, LATN; Shareholders are Encouraged to Contact the Firm

PR Newswire April 29, 2021

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Mountain Crest Acquisition Corp. II Merger

GlobeNewswire April 26, 2021

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Mountain Crest Acquisition Corp. II - MCAD

PR Newswire April 24, 2021

Better Therapeutics Launches Real World Evidence Study of Prescription Digital Therapeutic for Type 2 Diabetes

Business Wire April 14, 2021

Moore Kuehn Encourages MUDS, ROT, CAHC, and MCAD Investors to Contact Law Firm

GlobeNewswire April 12, 2021

SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of Mountain Crest Acquisition Corp. II (Nasdaq - MCAD)

ACCESSWIRE IA April 7, 2021

Better Therapeutics to Become Publicly Traded Prescription Digital Therapeutics Company via Merger with Mountain Crest Acquisition Corp. II

Business Wire April 7, 2021

Mountain Crest Acquisition Corp. II Announces that Common Stock and Rights to Commence Separate Trading on or about March 17, 2021

GlobeNewswire March 15, 2021